Viewing nowCrelorba Tablet 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

MFDS item code 201405753 · Approved 2014.12.04 · Insurance code 643703950
Improvement of dyslipidemia, inhibition of the progression of atherosclerosis, and reduction of cardiovascular disease risk
This medication is used as an adjunct in patients with primary hypercholesterolemia and mixed dyslipidemia when dietary changes and exercise alone are not sufficient. It is also used in patients with homozygous familial hypercholesterolemia along with dietary changes or other lipid-lowering therapies. It effectively lowers total cholesterol and LDL cholesterol levels to target levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis. It may also be used as an adjunct in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia who have LDL cholesterol levels exceeding certain criteria. It is beneficial for patients with primary dysbetalipoproteinemia and contributes to reducing the risk of myocardial infarction, stroke, and arterial revascularization in men over 50 years and women over 60 years with certain cardiovascular risk factors. Overall, it is used to improve cardiovascular health.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this product and continue it throughout the treatment period. This product may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this product to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this product to patients with active liver disease. 6. Race: Because systemic exposure to this product is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
2. Pediatric patients with heterozygous familial hypercholesterolemia (aged 10 to 17 years) The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be individualized according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. The safety and efficacy in children under 10 years of age have not been established.
This medication should not be administered to certain patients. For example, it should be avoided in patients with allergies to its components, severe liver problems, muscle disorders, and those with significantly impaired kidney function. Additionally, women who are pregnant or breastfeeding, or those of childbearing potential without adequate contraception should not take this medication. This medication requires special caution in patients at high risk of muscle-related side effects, such as those with moderate or severe renal impairment, hypothyroidism, a history of genetic muscle diseases, alcohol dependence, or those using certain concomitant medications. This medication contains lactose and should not be administered to patients with lactose intolerance or associated genetic disorders. It is important to periodically monitor liver function and muscle status during treatment. Patients who consume substantial amounts of alcohol or have a history of liver disease should be observed more closely, and treatment may be discontinued if liver enzyme levels are abnormally high. If symptoms such as muscle pain, weakness, or cramps occur, immediate notification to medical personnel and further evaluation are necessary. In cases of suspected severe muscle damage, treatment should be halted, and reevaluation of re-administration should be done after recovery. This medication may interact with certain drugs, so patients should inform their healthcare providers if they are taking other medications. Particularly, the risk of muscle side effects may be increased when used in combination with certain antiviral agents, immunosuppressants, antifungals, antibiotics, and fibrate agents. It should not be used during pregnancy or breastfeeding, and women planning to conceive should use appropriate contraception. In cases of overdose, there are no specific antidotes, and treatment should be symptomatic along with monitoring liver function and muscle enzyme levels. This medication does not significantly affect the ability to drive or operate machinery; however, caution is advised due to possible dizziness. Finally, this medication may result in higher systemic levels in Asian individuals, and dosage adjustments may be necessary. It is critical to consult healthcare personnel and follow their instructions before taking the medication.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-induced morbilliform eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, dysesthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. In addition, it is best to keep the medication at room temperature, between 1°C and 30°C, avoiding extreme cold or heat.
Yellow, round, film-coated tablet
30 tablets (10 tablets / PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.